Headache

 
FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine Treatment
September 14, 2021

The DHE nasal spray delivered pain relief at 2 hours for 66% of patients; 93% of those remained pain-free at 24 hours and 86% at 2 days post-dose.

Atogepant for Migraine Prevention Meets Primary, Secondary Endpoints
August 23, 2021

Oral CGRP inhibitor atogepant significantly reduced monthly headache days and improved daily function in adults with 4 to 14 headaches per month.

Seen in the ED: A Different Kind of Headache
April 19, 2021

A woman in her 50s who has a history of tension headache presents to the ED with a headache different from any she has had. Mild photophobia is the only finding on physical exam. Your dx?

Anosmia, Other Neurologic Symptoms Seen in Half of COVID-19 Patients at ED Presentation
March 16, 2021

Study: Anosmia, myalgias, and headache were the most common extrapulmonary symptoms seen in COVID-19 patients at first presentation, say investigators.

Cluster Headache Pain and Symptomatology
February 26, 2021

A recent survey queried cluster headache patients to compare cluster headache pain intensity to other painful disorders. The results, highlighted in this quick slideshow, may surprise.

Cannabis, Pain Relief, and the Sexes: Differential Benefit Explored
February 12, 2021

In animal models, pain relief from cannabis has been found to be greater in females; new research on pain relief from inhaled cannabis in regular users found something different.

Migraine with Aura Linked to Increased CVD in Women
June 23, 2020

Incident cardiovascular disease is significantly increased among women with migraine with aura vs migraineurs without aura and those who do not have migraine.

Less Than One-third of Diagnosed Migraine Patients Take Recommended Medications
June 18, 2020

Analysis of data from more than 21 000 migraineurs found that less than 1 in 3 take prescribed acute medications and less than 1 in 5 take prescribed preventive agents.

IM Migraine Relief: 5 Questions for Primary Care
September 10, 2019

Injectable medications for migraine are effective, inexpensive, and easy to store. Try these 5 questions on 5 you may want to have on hand.

Migraines, Cardiovascular Risk, & Vasoconstrictors
November 17, 2017

Migraine-especially with aura-is a CV risk factor, which makes treatment with ergots or triptans potentially problematic. The best approach?